Table I.
Association between miR-144 expression and clinicopathological features in PTC.
| Characteristics | n | High expression, n (%) | Low expression, n (%) | P-value |
|---|---|---|---|---|
| Sex | 0.027a | |||
| Male | 25 | 8 (32.0) | 17 (68.0) | |
| Female | 38 | 23 (60.5) | 15 (39.5) | |
| Age, years | 0.884 | |||
| <45 | 36 | 18 (50.0) | 18 (50.0) | |
| ≥45 | 27 | 13 (48.1) | 14 (51.9) | |
| Extrathyroidal extension | 0.701 | |||
| Yes | 30 | 14 (46.7) | 16 (53.3) | |
| No | 33 | 17 (51.5) | 16 (48.5) | |
| TNM staging | 0.503 | |||
| I–II | 38 | 20 (52.6) | 18 (47.4) | |
| III–IV | 25 | 11 (44.0) | 14 (56.0) | |
| Lymph node metastasis | 0.214 | |||
| Yes | 47 | 25 (53.2) | 22 (46.8) | |
| No | 16 | 6 (37.5) | 10 (62.5) | |
| Multicentricity | 0.383 | |||
| Yes | 27 | 15 (55.6) | 12 (44.4) | |
| No | 36 | 16 (44.4) | 20 (55.6) | |
| Tumor size, cm | <0.001a | |||
| <2 | 24 | 19 (79.2) | 5 (20.8) | |
| ≥2 | 39 | 12 (30.8) | 27 (69.2) |
a
Data that is statistically significant, P<0.05 using χ2.